Need Help?

Illumina GSA-MD v3 genotyping arrays for 183 samples

Genotyping arrays for 183 samples from patients with a neuroendocrine tumor of the small intestine. All samples have been hybridized on Illumina GSA-MD v3 arrays with standard automated protocols. Reading of the chips was performed on Illumina iScan+ scanners and this file is the result of primary analysis done using Illumina GenomeStudio software. It contains data for 147 tumors, 2 adenomas, 1 lymph node, 19 mesenteric nodules, 6 liver metastasis and 8 normal ileum samples.

Request Access

DUO:0000021
version: 2021-02-23

ethics approval required

This data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval.

ModifiersPlease provide details project synopsis for review by ethical / GDPR / Scientific Committee

DUO:0000022
version: 2021-02-23

geographical restriction

This data use modifier indicates that use is limited to within a specific geographic region.

ModifiersRestriction of use within countries enforcing a strict Patient Data / Personal Data Protection Regulation such as EU GDPR or EU approved countries

DUO:0000024
version: 2021-02-23

publication moratorium

This data use modifier indicates that requestor agrees not to publish results of studies until a specific date.

Modifiersall publications of project results involving direct or indirect use of the results must acknowledge the contribution support of : "Centre Leon Berard - CLB - Comprehensive Cancer Center, Lyon France" "Cancer Research Center of Lyon - CRCL - U1052 - UMR5286, Lyon France"

DUO:0000025
version: 2021-02-23

time limit on use

This data use modifier indicates that use is approved for a specific number of months.

Modifiers2 years maximum Exceptions possible in specific cases if approved by ethical committee

DUO:0000029
version: 2021-02-23

return to database or resource

This data use modifier indicates that the requestor must return derived/enriched data to the database/resource.

ModifiersUser shall provide a short summary report of its results to the dataset supplier for patient transparency purpose

DUO:0000044
version: 2021-02-23

population origins or ancestry research prohibited

This data use modifier indicates use for purposes of population, origin, or ancestry research is prohibited.

DUO:0000046
version: 2021-02-23

non-commercial use only

This data use modifier indicates that use of the data is limited to not-for-profit use.

Non commercial research only - GDPR compliant

Non Commercial Use only Please provide details project synopsis for review by ethical / GDPR / Scientific Committee - Prefered projects : Cancers, Digestive Diseases, Rare Diseases Restriction of use within countries enforcing a strict Patient Data / Personal Data Protection Regulation such as EU GDPR or EU approved countries 2 years maximum use - Exceptions possible in specific cases if approved by ethical committee All publications of project results involving direct or indirect use of the results must acknowledge the contribution support of : "Centre Leon Berard - CLB - Comprehensive Cancer Center, Lyon France" "Cancer Research Center of Lyon - CRCL - U1052 - UMR5286, Lyon France" User shall provide a short summary report of its results to the dataset supplier for patient transparency purpose Population origins or ancestry research prohibited

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000000642 Cancer Genomics

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF50000216467 cnv.gz 2.5 GB
1 File (2.5 GB)